Terms: = Ovarian cancer AND CD79A, ENSG00000105369, 973, P11912, MB-1, IGA
115 results:
1. Application of interpretable machine learning algorithms to predict distant metastasis in ovarian clear cell carcinoma.
Guo QH; Xie FC; Zhong FM; Wen W; Zhang XR; Yu XJ; Wang XL; Huang B; Li LP; Wang XZ
Cancer Med; 2024 Apr; 13(7):e7161. PubMed ID: 38613173
[TBL] [Abstract] [Full Text] [Related]
2. Linear iga bullous dermatosis associated with immunotherapy.
Momin B; Nguyen TF; Glade D; Messer A
Dermatol Online J; 2023 Dec; 29(6):. PubMed ID: 38478666
[TBL] [Abstract] [Full Text] [Related]
3. Association between Endometriosis and the Risk of ovarian, Endometrial, Cervical, and Breast cancer: A Population-Based Study from the U.S. National Inpatient Sample 2016-2019.
Al-Badawi IA; Abu-Zaid A; Alomar O; Alsabban M; Alsehaimi SO; Alqarni SMS; Alabdrabalamir SN; Baradwan S; Al Baalharith M; AlOdaini AA; Saleh SAK; Adly HM; Bukhari IA; Salem H
Curr Oncol; 2024 Jan; 31(1):472-481. PubMed ID: 38248117
[TBL] [Abstract] [Full Text] [Related]
4. Serum human epididymis protein 4 is associated with disease severity in patients with iga nephropathy.
Luo HL; He C; Xue H; Li M; Ji L; Xia Y
Clin Biochem; 2024 Jan; 123():110701. PubMed ID: 38048899
[TBL] [Abstract] [Full Text] [Related]
5. Targeting intracellular oncoproteins with dimeric iga promotes expulsion from the cytoplasm and immune-mediated control of epithelial cancers.
Biswas S; Mandal G; Anadon CM; Chaurio RA; Lopez-Bailon LU; Nagy MZ; Mine JA; Hänggi K; Sprenger KB; Innamarato P; Harro CM; Powers JJ; Johnson J; Fang B; Eysha M; Nan X; Li R; Perez BA; Curiel TJ; Yu X; Rodriguez PC; Conejo-Garcia JR
Immunity; 2023 Nov; 56(11):2570-2583.e6. PubMed ID: 37909039
[TBL] [Abstract] [Full Text] [Related]
6. Polymeric immunoglobulin receptor (pIgR) in cancer.
Chae J; Choi J; Chung J
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17683-17690. PubMed ID: 37897659
[TBL] [Abstract] [Full Text] [Related]
7. TRAF3 suppression encourages B cell recruitment and prolongs survival of microbiome-intact mice with ovarian cancer.
Zorea J; Motro Y; Mazor RD; Carmi YK; Shulman Z; Mahajna J; Moran-Gilad J; Elkabets M
J Exp Clin Cancer Res; 2023 May; 42(1):107. PubMed ID: 37121997
[TBL] [Abstract] [Full Text] [Related]
8. Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma.
Handley KF; Mehta S; Martin AL; Biswas S; Maharaj K; Nagy MZ; Mine JA; Cortina C; Yu X; Sprenger K; Mandal G; Innamarato P; Powers JJ; Harro CM; Chaurio RA; Anadon CM; Shahzad MM; Flores I; Conejo-Garcia JR
Gynecol Oncol; 2023 Jun; 173():114-121. PubMed ID: 37121178
[TBL] [Abstract] [Full Text] [Related]
9. p53 and ovarian carcinoma survival: an ovarian Tumor Tissue Analysis consortium study.
Köbel M; Kang EY; Weir A; Rambau PF; Lee CH; Nelson GS; Ghatage P; Meagher NS; Riggan MJ; Alsop J; Anglesio MS; Beckmann MW; Bisinotto C; Boisen M; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; Deen S; El-Bahrawy MA; Elishaev E; Erber R; Fereday S; ; Fischer A; Gayther SA; Barquin-Garcia A; Gentry-Maharaj A; Gilks CB; Gronwald H; Grube M; Harnett PR; Harris HR; Hartkopf AD; Hartmann A; Hein A; Hendley J; Hernandez BY; Huang Y; Jakubowska A; Jimenez-Linan M; Jones ME; Kennedy CJ; Kluz T; Koziak JM; Lesnock J; Lester J; Lubiński J; Longacre TA; Lycke M; Mateoiu C; McCauley BM; McGuire V; Ney B; Olawaiye A; Orsulic S; Osorio A; Paz-Ares L; Ramón Y Cajal T; Rothstein JH; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Singh N; Steed H; Storr SJ; Talhouk A; Traficante N; Wang C; Whittemore AS; Widschwendter M; Wilkens LR; Winham SJ; Benitez J; Berchuck A; Bowtell DD; Candido Dos Reis FJ; Campbell I; Cook LS; DeFazio A; Doherty JA; Fasching PA; Fortner RT; García MJ; Goodman MT; Goode EL; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Kommoss S; Le ND; Martin SG; Menon U; Modugno F; Pharoah PD; Schildkraut JM; Sieh W; Staebler A; Sundfeldt K; Swerdlow AJ; Ramus SJ; Brenton JD
J Pathol Clin Res; 2023 May; 9(3):208-222. PubMed ID: 36948887
[TBL] [Abstract] [Full Text] [Related]
10. The Impact of Sarcopenia Onset Prior to cancer Diagnosis on cancer Survival: A National Population-Based Cohort Study Using Propensity Score Matching.
Su CH; Chen WM; Chen MC; Shia BC; Wu SY
Nutrients; 2023 Mar; 15(5):. PubMed ID: 36904245
[TBL] [Abstract] [Full Text] [Related]
11. Peripheral and tumor-infiltrating immune cells are correlated with patient outcomes in ovarian cancer.
Zhang W; Ling Y; Li Z; Peng X; Ren Y
Cancer Med; 2023 Apr; 12(8):10045-10061. PubMed ID: 36645174
[TBL] [Abstract] [Full Text] [Related]
12. Profiling the immune landscape in mucinous ovarian carcinoma.
Meagher NS; Hamilton P; Milne K; Thornton S; Harris B; Weir A; Alsop J; Bisinoto C; Brenton JD; Brooks-Wilson A; Chiu DS; Cushing-Haugen KL; Fereday S; Garsed DW; Gayther SA; Gentry-Maharaj A; Gilks B; Jimenez-Linan M; Kennedy CJ; Le ND; Piskorz AM; Riggan MJ; Shah M; Singh N; Talhouk A; Widschwendter M; Bowtell DDL; Candido Dos Reis FJ; Cook LS; Fortner RT; García MJ; Harris HR; Huntsman DG; Karnezis AN; Köbel M; Menon U; Pharoah PDP; Doherty JA; Anglesio MS; Pike MC; Pearce CL; Friedlander ML; DeFazio A; Nelson BH; Ramus SJ
Gynecol Oncol; 2023 Jan; 168():23-31. PubMed ID: 36368129
[TBL] [Abstract] [Full Text] [Related]
13. Pathways to diagnosis of endometrial and ovarian cancer in the 45 and Up Study cohort.
Yap S; Vassallo A; Goldsbury D; O'Connell DL; Brand A; Emery J; DeFazio A; Canfell K; Steinberg J
Cancer Causes Control; 2023 Jan; 34(1):47-58. PubMed ID: 36209449
[TBL] [Abstract] [Full Text] [Related]
14. The Optimal Cut-Off Point of the ADNEX Model for the Prediction of the ovarian cancer Risk.
Lam Huong L; Thi Phuong Dung N; Hoang Lam V; Tran Thao Nguyen N; Minh Tam L; Vu Quoc Huy N
Asian Pac J Cancer Prev; 2022 Aug; 23(8):2713-2718. PubMed ID: 36037125
[TBL] [Abstract] [Full Text] [Related]
15. Cysteine conjugate beta-lyase 2 (CCBL2) expression as a prognostic marker of survival in breast cancer patients.
Meng X; Wang L; He M; Yang Z; Jiao Y; Hu Y; Wang K
PLoS One; 2022; 17(6):e0269998. PubMed ID: 35771747
[TBL] [Abstract] [Full Text] [Related]
16. Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-antibody encephalitis.
Al-Diwani A; Theorell J; Damato V; Bull J; McGlashan N; Green E; Kienzler AK; Harrison R; Hassanali T; Campo L; Browne M; Easton A; Soleymani Majd H; Tenaka K; Iorio R; Dale RC; Harrison P; Geddes J; Quested D; Sharp D; Lee ST; Nauen DW; Makuch M; Lennox B; Fowler D; Sheerin F; Waters P; Leite MI; Handel AE; Irani SR
Brain; 2022 Aug; 145(8):2742-2754. PubMed ID: 35680425
[TBL] [Abstract] [Full Text] [Related]
17. Screening and risk reducing surgery for endometrial or ovarian cancers in Lynch syndrome: a systematic review.
Lim N; Hickey M; Young GP; Macrae FA; Kelly C
Int J Gynecol Cancer; 2022 May; 32(5):646-655. PubMed ID: 35437274
[TBL] [Abstract] [Full Text] [Related]
18. How to improve O-RADS MRI score for rating adnexal masses with cystic component?
Assouline V; Dabi Y; Jalaguier-Coudray A; Stojanovic S; Millet I; Reinhold C; Bazot M; Thomassin-Naggara I;
Eur Radiol; 2022 Sep; 32(9):5943-5953. PubMed ID: 35332409
[TBL] [Abstract] [Full Text] [Related]
19. Nurse-led exercise and cognitive-behavioral care against nurse-led usual care between and after chemotherapy cycles in Han Chinese women of ovarian cancer with moderate to severe levels of cancer-related fatigue: A retrospective analysis of the effectiveness.
Yang W; Xi J; Guo L; Cao Z
Medicine (Baltimore); 2021 Nov; 100(44):e27317. PubMed ID: 34871205
[TBL] [Abstract] [Full Text] [Related]
20. Evaluation of safety and efficacy of apatinib combination with chemotherapy for ovarian cancer treatment: a systematic review and meta-analysis.
Qi J; Liu E; Yue H; Chen G; Liu Y; Chen J
Ann Palliat Med; 2021 Sep; 10(9):9902-9913. PubMed ID: 34551570
[TBL] [Abstract] [Full Text] [Related]
[Next]
